Oral vs Injectable Peptides: What Does the Science Say?

What bioavailability means

Bioavailability is how much of a substance actually reaches your bloodstream and the tissues where it can act. Your stomach is built to break peptides down with acid and enzymes, so for most peptides an oral dose is largely destroyed before it can do anything. That is exactly why insulin is still injected rather than swallowed.

Why BPC-157 is an interesting exception

Because its sequence comes from a protein found in gastric juice, BPC-157 is notably stable in stomach acid, which is what makes oral dosing worth discussing at all. In animal studies, oral BPC-157 has shown clear effects on the gut itself, where the peptide contacts the tissue directly. Background on the molecule is in our BPC 157 post op.

The honest gap: no published study has measured how much oral BPC-157 gets absorbed into the bloodstream in any species. Oral dosing looks reasonable for gut-related effects, but the case for it reaching a knee or shoulder is much weaker. Absorption percentages quoted online are estimates, not results.

Why TB-500 is injected

TB-500 does not share that acid stability. Taken orally it would be broken down before it could work, which is why it is given by subcutaneous injection. For a systemic peptide meant to travel through the body, injection is the route that preserves it. See best peptides after surgery for the mechanism differences.

So which should you choose?

It depends on the peptide and the goal. For gut-focused effects, oral BPC-157 has a logical basis. For musculoskeletal or whole-body goals, research protocols overwhelmingly use injection. No peptide route here is FDA-approved, so this is a conversation for a qualified prescriber, and the product still needs to come from a legitimate source.